CD8A and neoplasm: Further, adoptive transfer of CD8+T cells from transgenic mice vaccinated with the MamA2.1 peptide and either ODN2006 or M362 demonstrated significantly reduced tumor growth compared to CD8+T cells transferred from the MamA2.1 peptide alone or with vaccination or co-vaccination with the MamA2.1 peptide and ODN2216.